Search results for : akt3 - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Search Results for: akt3

Drugs (11)

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
A-443654	KIN001-139	AKT1, AKT2, AKT3	PI3K/MTOR signaling	10172943	GDSC1	397	MGH
AKT inhibitor VIII	Akti-1/2, KIN001-102	AKT1, AKT2, AKT3	PI3K/MTOR signaling	10196499	GDSC1	877	MGH
AKT inhibitor VIII	Akti-1/2, KIN001-102	AKT1, AKT2, AKT3	PI3K/MTOR signaling	10196499	GDSC1	913	MGH
AZD5363		AKT1, AKT2, AKT3, ROCK2	Other, kinases	25227436, 42602260	GDSC2	958	SANGER
Afuresertib	GSK2110183, GSK2110183C	AKT1, AKT2, AKT3	PI3K/MTOR signaling	46843057	GDSC2	957	SANGER
BAY AKT1		AKT1, AKT2, AKT3	Apoptosis regulation		GDSC1	835	SANGER
GSK2110183B		AKT1, AKT2, AKT3	PI3K/MTOR signaling		GDSC2	717	SANGER
GSK690693	GSK 690693, GSK-690693	AKT1, AKT2, AKT3	PI3K/MTOR signaling	16725726	GDSC1	910	MGH
Ipatasertib	GDC0068, GDC 0068, GDC-0068	AKT1, AKT, AKT3	PI3K/MTOR signaling	24788740	GDSC2	958	SANGER
Uprosertib	GSK2141795, GSK2141795C, GSK-2141795	AKT1, AKT2, AKT3	PI3K/MTOR signaling	51042438	GDSC2	898	SANGER
Uprosertib	GSK2141795, GSK2141795C, GSK-2141795	AKT1, AKT2, AKT3	PI3K/MTOR signaling	51042438	GDSC2	736	SANGER

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).